Jimsum Life Sciences Private Limited - Due diligence report

A 360° intelligence report on Jimsum Life Sciences Private Limited: trust score, financial health, credit view, compliance, directors, growt…

2017-08-07 Mumbai, Maharashtra Active Unlisted Active Compliant
Share
Connect MCP
JL Jimsum Life Sciences Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Jimsum Life Sciences Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
90/100
Trust Score
Low Risk

Jimsum Life Sciences Private Limited is assessed as Low Risk with a Trust Score of 90/100. Jimsum Life Sciences Private Limited is an active private limited indian non-government company incorporated in 2017, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 04 Aug 2026 from the latest processed filings. Jimsum Life Sciences Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
90/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
92/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
85/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
85/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 85/100 Low Risk
  • Liabilities ≈ 38% EBITDA - serviceable.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Moderate gearing (D/E 1.42).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 1 open (1.62 cr) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
Hdfc Bank Limited1 48.0 cr
Compliance Score: 92/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Delayed payments to MSME suppliers disclosed (26 disclosure(s)).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
GEETIKA 01234567 Director 01/04/2018 6 yrs Approved
SUNIL KAVATRA 01234567 Director 01/04/2018 6 yrs Approved
VIKRAM HIRALAL SONI 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
1 allotment(s) · 3 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 85 · Distress 80
Growth signals & trust indicators
Revenue acceleration: +2.1x over 4 year(s).
Latest year revenue grew 24%.
Asset base grew 0.86 - capacity expansion.
Operating for 8 years.
Active GST registration(s).
Distress signals & risk flags
Profit declined two years in a row.
1 open charge(s) registered - assets are encumbered.
MSME payment delays disclosed - latest outstanding 20.54 Lakh.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence88/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment90/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 1.62 cr already registered.
  • Compliance record supports lending.
Investor view90/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 3 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 13 events
10 Nov 2025
Charge created
Hdfc Bank Limited - 1.62 cr
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
29 Sep 2018
Director ceased
SUNIL KAVATRA
31 Mar 2018
Share transfer (FY 2018)
500.00000000 shares to Priya Jimi Doshi
Share transfer (FY 2018)
500.00000000 shares to Geetika Sunil Kavatra
Share transfer (FY 2018)
100.00000000 shares to Sunil Om Prakash Kavatra
23 Mar 2018
Securities allotted
90000 Equity Shares - 9.00 Lakh raised
10 Feb 2018
Director appointed
SUNIL KAVATRA (Director)
10 Jan 2018
Director ceased
PRIYA JIMI DOSHI
07 Aug 2017
Incorporated
Registered with Roc Mumbai
Director appointed
GEETIKA (Director)
Director appointed
VIKRAM HIRALAL SONI (Director)
10

Key Observations

Auto-generated from the data above
Revenue grew 61% over the last 4 financial year(s).
Net profit margin moved from 38% to 1.42.
Debt-to-equity stands at 2.1x - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Deepesh Chemicals Private Limited U18101RJ2010PTC030652 Pali Mwr, Rajasthan, India
Agr Lighting Private Limited U51909DL2021PTC384707 Delhi, Delhi, India
As Trade Solutions Private Limited U51101HR2015PTC056268 Badshahpur, Haryana, India
Tradeniger Impex Private Limited U51496MH2005PTC151762 Mumbai, Maharashtra, India
Annalynn Wire Solutions Private Limited U52609DL2022PTC404984 Delhi, Delhi, India
Raimata Impex Private Limited U51909WB2004PTC099279 Kolkata, West Bengal, India
Esrdns Private Limited U32109DL2020PTC371671 Delhi, Delhi, India
Patson Toolstech India Private Limited U74999GJ2018PTC101286 Ahmedabad, Gujarat, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Jimsum Life Sciences Private Limited before audits and certifications: compliance score 92/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Jimsum Life Sciences Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 85/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 85/100, margin trends, ownership structure and peer set for Jimsum Life Sciences Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 90/100, distress signals and MSME payment-delay disclosures - know whether Jimsum Life Sciences Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Jimsum Life Sciences Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Jimsum Life Sciences Private Limited an active company?

Jimsum Life Sciences Private Limited has MCA status “Active” with a compliance score of 92/100 (Low Risk).

Is Jimsum Life Sciences Private Limited financially healthy?

Jimsum Life Sciences Private Limited has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.

Should I do business with Jimsum Life Sciences Private Limited?

Its overall Trust Score is 90/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Jimsum Life Sciences Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.

Does Jimsum Life Sciences Private Limited have loans or charges against its assets?

1 open charge(s) are registered against its assets.

Is Jimsum Life Sciences Private Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 92/100 (Low Risk).

Is it risky to lend to Jimsum Life Sciences Private Limited?

Its Credit Risk Score is 85/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.